Effects of Dietary Phosphate and Calcium Intake on Fibroblast Growth Factor-23

Overview

Journal Clin J Am Soc Nephrol

Specialty Nephrology

Date 2010 Oct 30

PMID 21030580

Citations 110

Authors

Marc G Vervloet

Frans J van Ittersum

Rahel M Buttler

Annemieke C Heijboer

Marinus A Blankenstein

Piet M Ter Wee

Affiliations

Soon will be listed here.

Abstract

Background And Objectives: Little is known about the influence of dietary phosphate intake on fibroblast growth factor-23 (FGF23) and its subsequent effects on vitamin D levels. This study addresses changes in intact FGF23 (iFGF23) and C-terminal FGF23 (cFGF23), phosphaturia, and levels of vitamin D on high and low phosphate and calcium intake.

Design, Setting, Participants, & Measurements: Ten healthy subjects adhered to a diet low or high in phosphate and calcium content for 36 hours each with a 1-week interval during which subjects adhered to their usual diet. Serum phosphate, calcium, vitamin D metabolites, parathyroid hormone (PTH), and FGF23 levels (cFGF23 and iFGF23) were measured several times a day. Phosphate, calcium, and creatinine excretion was measured in 24-hour urine on all study days.

Results: Serum phosphate levels and urinary phosphate increased during high dietary phosphate intake (from 1.11 to 1.32 mmol/L, P<0.0001 and 21.6 to 28.8 mmol/d, P=0.0005, respectively). FGF23 serum levels increased during high dietary phosphate/calcium intake (cFGF23 from 60 to 72 RU/ml, P<0.001; iFGF23 from 33 to 37 ng/L, P=0.003), whereas PTH declined. 1,25-dihydroxyvitamin D (1,25D) showed an inverse relation with FGF23.

Conclusions: Variation in dietary phosphate and calcium intake induces changes in FGF23 (on top of a circadian rhythm) and 1,25D blood levels as well as in urinary phosphate excretion. These changes are detectable the day after the change in the phosphate content of meals. Higher FGF23 levels are associated with phosphaturia and a decline in 1,25D levels.

Citing Articles

Phosphorus-independent role of FGF23 in erythropoiesis and iron homeostasis.

Park M, Agoro R, Jankauskas S, Le Henaff C, Sitara D PLoS One. 2024; 19(12):e0315228.

PMID: 39666728 PMC: 11637385. DOI: 10.1371/journal.pone.0315228.

Controlled dietary phosphate loading in healthy young men elevates plasma phosphate and FGF23 levels.

Gerber J, Pastor Arroyo E, Pastor J, Correia M, Rudloff S, Moe O Pflugers Arch. 2024; 477(3):495-508.

PMID: 39601886 PMC: 11825603. DOI: 10.1007/s00424-024-03046-4.

Young adults' circulating FGF23 and α-klotho and their relationship with habitual dietary acid load and phosphorus intake during growth.

Franco L, Derakhshandeh-Rishehri S, Nothlings U, Hartmann M, Herder C, Kalhoff H Sci Rep. 2024; 14(1):27784.

PMID: 39537770 PMC: 11561314. DOI: 10.1038/s41598-024-79636-0.

Association of hyperphosphatemia with renal prognosis in patients with autosomal dominant polycystic kidney disease.

Nitta K, Kataoka H, Manabe S, Makabe S, Akihisa T, Ushio Y Clin Exp Nephrol. 2024; 29(1):75-82.

PMID: 39322826 DOI: 10.1007/s10157-024-02568-6.

Inorganic phosphate additives in meals and adaptations to 5-days of dietary inorganic phosphate loading alter acute calcium homeostasis in two randomized cross-over studies in healthy adults.

Turner M, Mazzetti T, Neville K, Ward E, Munroe J, Adams M JBMR Plus. 2024; 8(8):ziae075.

PMID: 39238566 PMC: 11376221. DOI: 10.1093/jbmrpl/ziae075.

References

Tenenhouse H, Martel J, Gauthier C, Zhang M, Portale A . Renal expression of the sodium/phosphate cotransporter gene, Npt2, is not required for regulation of renal 1 alpha-hydroxylase by phosphate. Endocrinology. 2001; 142(3):1124-9. DOI: 10.1210/endo.142.3.8029. View

Ter Wee P, Geerlings W, Rosman J, Sluiter W, van der Geest S, Donker A . Testing renal reserve filtration capacity with an amino acid solution. Nephron. 1985; 41(2):193-9. DOI: 10.1159/000183580. View

Block G, Levin N, Port F . Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study. Am J Kidney Dis. 1998; 31(4):607-17. DOI: 10.1053/ajkd.1998.v31.pm9531176. View

Gutierrez O, Isakova T, Rhee E, Shah A, Holmes J, Collerone G . Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease. J Am Soc Nephrol. 2005; 16(7):2205-15. DOI: 10.1681/ASN.2005010052. View

Berndt T, Craig T, McCormick D, Lanske B, Sitara D, Razzaque M . Biological activity of FGF-23 fragments. Pflugers Arch. 2007; 454(4):615-23. PMC: 3818792. DOI: 10.1007/s00424-007-0231-5. View

Twisk J . Longitudinal data analysis. A comparison between generalized estimating equations and random coefficient analysis. Eur J Epidemiol. 2004; 19(8):769-76. DOI: 10.1023/b:ejep.0000036572.00663.f2. View

Liu S, Quarles L . How fibroblast growth factor 23 works. J Am Soc Nephrol. 2007; 18(6):1637-47. DOI: 10.1681/ASN.2007010068. View

Bushinsky D, Riera G, Favus M, Coe F . Evidence that blood ionized calcium can regulate serum 1,25(OH)2D3 independently of parathyroid hormone and phosphorus in the rat. J Clin Invest. 1985; 76(4):1599-604. PMC: 424140. DOI: 10.1172/JCI112143. View

Kalantar-Zadeh K, Gutekunst L, Mehrotra R, Kovesdy C, Bross R, Shinaberger C . Understanding sources of dietary phosphorus in the treatment of patients with chronic kidney disease. Clin J Am Soc Nephrol. 2010; 5(3):519-30. DOI: 10.2215/CJN.06080809. View

10.

Hruska K, Mathew S, Lund R, Qiu P, Pratt R . Hyperphosphatemia of chronic kidney disease. Kidney Int. 2008; 74(2):148-57. PMC: 2735026. DOI: 10.1038/ki.2008.130. View

11.

Nishida Y, Taketani Y, Yamanaka-Okumura H, Imamura F, Taniguchi A, Sato T . Acute effect of oral phosphate loading on serum fibroblast growth factor 23 levels in healthy men. Kidney Int. 2006; 70(12):2141-7. DOI: 10.1038/sj.ki.5002000. View

12.

Antoniucci D, Yamashita T, Portale A . Dietary phosphorus regulates serum fibroblast growth factor-23 concentrations in healthy men. J Clin Endocrinol Metab. 2006; 91(8):3144-9. DOI: 10.1210/jc.2006-0021. View

13.

El-Hajj Fuleihan G, Klerman E, Brown E, Choe Y, Brown E, Czeisler C . The parathyroid hormone circadian rhythm is truly endogenous--a general clinical research center study. J Clin Endocrinol Metab. 1997; 82(1):281-6. DOI: 10.1210/jcem.82.1.3683. View

14.

Ito N, Fukumoto S, Takeuchi Y, Takeda S, Suzuki H, Yamashita T . Effect of acute changes of serum phosphate on fibroblast growth factor (FGF)23 levels in humans. J Bone Miner Metab. 2007; 25(6):419-22. DOI: 10.1007/s00774-007-0779-3. View

15.

Ervin R, Wang C, Wright J, Kennedy-Stephenson J . Dietary intake of selected minerals for the United States population: 1999-2000. Adv Data. 2004; (341):1-5. View

16.

Heijboer A, Levitus M, Vervloet M, Lips P, Ter Wee P, Dijstelbloem H . Determination of fibroblast growth factor 23. Ann Clin Biochem. 2009; 46(Pt 4):338-40. DOI: 10.1258/acb.2009.009066. View

17.

Tanaka Y, DeLuca H . The control of 25-hydroxyvitamin D metabolism by inorganic phosphorus. Arch Biochem Biophys. 1973; 154(2):566-74. DOI: 10.1016/0003-9861(73)90010-6. View

18.

Haussler M, Hughes M, Baylink D, Littledike E, Cork D, Pitt M . Influence of phosphate depletion on the biosynthesis and circulating level of 1alpha,25-dihydroxyvitamin D. Adv Exp Med Biol. 1977; 81:233-50. DOI: 10.1007/978-1-4613-4217-5_24. View

19.

Ben-Dov I, Galitzer H, Lavi-Moshayoff V, Goetz R, Kuro-O M, Mohammadi M . The parathyroid is a target organ for FGF23 in rats. J Clin Invest. 2007; 117(12):4003-8. PMC: 2066196. DOI: 10.1172/JCI32409. View

20.

Dhingra R, Sullivan L, Fox C, Wang T, DAgostino Sr R, Gaziano J . Relations of serum phosphorus and calcium levels to the incidence of cardiovascular disease in the community. Arch Intern Med. 2007; 167(9):879-85. DOI: 10.1001/archinte.167.9.879. View